Symbi Medical
Grant in 2021
Symbi Medical is a digital health company that provides a procedural care navigation platform designed to help patients manage their health before and after medical procedures. The platform is HIPAA and PHIPA compliant, facilitating thousands of patient interactions through seamless integration with electronic medical record (EMR) vendors. By delivering personalized care journeys at scale, Symbi aids healthcare organizations in enhancing clinical decision-making, managing risk, and improving health outcomes for their patient populations. The company boasts a team of medical advisors affiliated with prominent institutions such as the University of Michigan, St. Michael's Hospital, and Nova Scotia Health. Symbi Medical was acquired by Blue Charm Adherence in March 2021, further expanding its capabilities in the healthcare sector.
Symbi Medical
Grant in 2020
Symbi Medical is a digital health company that provides a procedural care navigation platform designed to help patients manage their health before and after medical procedures. The platform is HIPAA and PHIPA compliant, facilitating thousands of patient interactions through seamless integration with electronic medical record (EMR) vendors. By delivering personalized care journeys at scale, Symbi aids healthcare organizations in enhancing clinical decision-making, managing risk, and improving health outcomes for their patient populations. The company boasts a team of medical advisors affiliated with prominent institutions such as the University of Michigan, St. Michael's Hospital, and Nova Scotia Health. Symbi Medical was acquired by Blue Charm Adherence in March 2021, further expanding its capabilities in the healthcare sector.
Proteoform Scientific
Seed Round in 2019
Proteoform empowers researchers with new technology to simplify protein sample preparation in both top-down and bottom-up proteomics. The Company’s first commercialized product, the ProTrap XG, is a disposable two-stage cartridge that delivers fast, reproducible, and robust results with unmatched protein purity of 99.8%, recovery greater than 95%, and workflow simplicity.
It was founded in 2018 and is headquartered in Halifax, Nova Scotia.
Coloursmith Labs
Seed Round in 2019
Coloursmith Labs Inc. is an optical filtering technology company based in Halifax, Canada, founded in 2018. The company specializes in developing advanced optical filters for contact lenses, designed to enhance color saturation and assist individuals with color vision deficiencies. By focusing on innovative materials and the principles of light and optics, Coloursmith Labs aims to create products that offer protection from harmful light while addressing chromatic applications. Their mission centers on integrating science and creativity to expand the potential of human vision, thereby improving the quality of life for their users.
Invisible Agents
Grant in 2019
Invisible Agents is a Halifax-based company, established in 2018, that specializes in developing technology solutions to enhance fundraising efforts for non-profits and churches. By leveraging machine learning and analytics, the company provides a tailored platform designed to bridge the gap between organizational data and effective fundraising actions. Invisible Agents empowers these organizations to utilize advanced technology, such as data visualization and cross-channel communication, to optimize their fundraising strategies. The company's focus is on making data-driven fundraising accessible and actionable, enabling non-profits to raise more funds and improve their overall effectiveness in achieving their missions.
Symbi Medical
Grant in 2019
Symbi Medical is a digital health company that provides a procedural care navigation platform designed to help patients manage their health before and after medical procedures. The platform is HIPAA and PHIPA compliant, facilitating thousands of patient interactions through seamless integration with electronic medical record (EMR) vendors. By delivering personalized care journeys at scale, Symbi aids healthcare organizations in enhancing clinical decision-making, managing risk, and improving health outcomes for their patient populations. The company boasts a team of medical advisors affiliated with prominent institutions such as the University of Michigan, St. Michael's Hospital, and Nova Scotia Health. Symbi Medical was acquired by Blue Charm Adherence in March 2021, further expanding its capabilities in the healthcare sector.
CarbonCure
Corporate Round in 2018
CarbonCure Technologies Inc. is a Canadian company that specializes in technology designed to sequester carbon dioxide (CO2) in concrete production. Founded in 2007 and headquartered in Dartmouth, Nova Scotia, the company provides a retrofit solution for existing concrete plants, allowing producers to incorporate waste CO2 from industrial emitters into their concrete products. During manufacturing, this CO2 is chemically converted into solid mineral carbonates, enhancing the strength of the concrete while reducing its carbon footprint. CarbonCure's innovative approach enables concrete manufacturers to produce green concrete without compromising quality or cost, thereby facilitating a shift towards sustainable building practices. The company also offers marketing and environmental reporting services to support its customers in the growing green building market. By licensing its technology at a low capital expenditure, CarbonCure generates a recurring revenue stream while contributing to the reduction of greenhouse gas emissions in the concrete industry.
Aqualitas
Venture Round in 2018
Aqualitas Inc. is a Canadian company specializing in the production and sale of medical cannabis products. Founded in 2014 and headquartered in Bedford, Nova Scotia, Aqualitas utilizes an innovative aquaponics growing platform, which integrates aquaculture and hydroponics, to cultivate cannabis in a sustainable and efficient manner. The company prioritizes water quality and employs rigorous testing standards to ensure that its products meet high safety, purity, and consistency levels. Aqualitas is committed to providing top-quality cannabis products to its clients, reflecting its scientific approach to cultivation and dedication to excellence.
Aqualitas
Seed Round in 2018
Aqualitas Inc. is a Canadian company specializing in the production and sale of medical cannabis products. Founded in 2014 and headquartered in Bedford, Nova Scotia, Aqualitas utilizes an innovative aquaponics growing platform, which integrates aquaculture and hydroponics, to cultivate cannabis in a sustainable and efficient manner. The company prioritizes water quality and employs rigorous testing standards to ensure that its products meet high safety, purity, and consistency levels. Aqualitas is committed to providing top-quality cannabis products to its clients, reflecting its scientific approach to cultivation and dedication to excellence.
Harbr Inc. is a technology company that specializes in artificial intelligence-driven software solutions for the construction industry. Founded in 2016 and headquartered in Halifax, Nova Scotia, Harbr develops tools designed to enhance project management by organizing and managing data effectively. Its offerings include a range of construction management solutions, such as the free Super Schedule that provides daily logs for user and site safety, the Pro version that facilitates team connectivity on job sites, and the Enterprise solution that links multiple job sites and teams. Additionally, Harbr's platform streamlines the qualification process for lenders by automating document evaluation and data extraction, allowing businesses to reduce manual intake efforts and improve scalability.
PhotoDynamic
Seed Round in 2016
PhotoDynamic, Inc. is a life sciences and biotechnology company based in Halifax, Canada, founded in 2012. The company specializes in developing light-activated natural products designed to remove dental plaque. Its innovative approach utilizes natural extracts from a wild plant native to Nova Scotia, combined with a light-emitting medical device. This platform targets various health and wellness needs, offering solutions that address both over-the-counter and pharmaceutical markets. By focusing on antimicrobial properties activated by light, PhotoDynamic aims to assist healthcare professionals in reducing gum inflammation and effectively managing plaque buildup, particularly around braces and gum lines.
Swarmio Media
Seed Round in 2016
Swarmio Media Group Inc., established in 2014 and headquartered in Whitby, Canada, specializes in providing technological solutions for the gaming and real-time application industries. The company's core product, Swarmio Hive, is a cloud-based computing grid platform that leverages artificial intelligence and swarm intelligence algorithms to drastically reduce latency, ensuring a seamless gaming experience. Swarmio Media serves clients in North America, Europe, Asia, and Oceania, partnering with telecom operators and supporting a wide range of gaming and enterprise applications.
Swept is a technology company that specializes in developing software solutions for the janitorial industry. Founded in August 2014 by Matt Cooper and Michael Brown, and based in Nova Scotia, Swept offers an operational cleaning management platform aimed at enhancing the efficiency of commercial cleaning businesses. The platform facilitates communication between cleaning companies, their employees, and customers, while also supporting real-time inspections and supply orders. By providing these tools, Swept enables cleaning companies to improve their operational effectiveness, increase profitability, and enhance customer retention.
InNetwork
Seed Round in 2014
InNetwork Inc. is a Canadian company that specializes in providing tools for marketers to create and manage social media influencer outreach campaigns. Established in 2012, the company operates from Halifax and Toronto, offering a platform that enables brands to identify and engage trusted social media influencers. InNetwork’s solution is designed to simplify the influencer outreach process, allowing marketers to target specific customer demographics through detailed audience segmentation data. The platform not only connects marketers with a vetted network of influencers but also tracks and measures the effectiveness of influencer activities, ensuring that brands can communicate their messages efficiently and effectively. By streamlining the campaign process, InNetwork helps agencies and brand managers execute influencer outreach at scale, ultimately improving campaign results while saving time. InNetwork operates as a subsidiary of gShift Labs Inc.
CarbonCure
Series B in 2013
CarbonCure Technologies Inc. is a Canadian company that specializes in technology designed to sequester carbon dioxide (CO2) in concrete production. Founded in 2007 and headquartered in Dartmouth, Nova Scotia, the company provides a retrofit solution for existing concrete plants, allowing producers to incorporate waste CO2 from industrial emitters into their concrete products. During manufacturing, this CO2 is chemically converted into solid mineral carbonates, enhancing the strength of the concrete while reducing its carbon footprint. CarbonCure's innovative approach enables concrete manufacturers to produce green concrete without compromising quality or cost, thereby facilitating a shift towards sustainable building practices. The company also offers marketing and environmental reporting services to support its customers in the growing green building market. By licensing its technology at a low capital expenditure, CarbonCure generates a recurring revenue stream while contributing to the reduction of greenhouse gas emissions in the concrete industry.
DeCell Technologies
Seed Round in 2013
DeCell Technologies Inc. is an emerging biomedical device manufacturer that is developing advanced tissue products for use in wound healing and surgical reconstructions. DeCell Technologies’ main facilities are located in Halifax, Nova Scotia, Canada.
Performance Genomics
Seed Round in 2013
Performance Genomics Inc. is a genomics-based research company headquartered in Truro, Canada, focusing on the development of genetic products aimed at enhancing fertility, reproduction, and reproductive longevity in both agricultural species and humans. Established in 1999, the company employs a unique Mouse Model System to identify genes that influence fertility and reproductive longevity across various mammals. Performance Genomics develops DNA sequence-based predictive algorithms, known as Genome Apps, to inform livestock breeding practices and assess human reproductive health. The company has successfully demonstrated predictive capabilities for the productive lifetime of Holstein dairy cows through its earlier research. Its business model includes licensing livestock breeding and animal health applications to industry partners in exchange for milestones and royalties. Additionally, the company seeks to establish long-term partnerships and funding for research and development in human applications and consumer genomics. Performance Genomics collaborates with notable research institutions, including Genome Quebec and Dalhousie University, to further its mission in the genomics field.
Karma Gaming
Series A in 2013
Karma Gaming is a Halifax, Nova Scotia-based company specializing in the development of video games for regulated lotteries. With over 30 years of combined experience in the gaming industry, the company's team possesses a strong entrepreneurial background and a comprehensive understanding of online casual and social gaming. Karma Gaming has created a platform that integrates elements of casual and social game mechanics, allowing customers to engage in online games that offer cash prizes. This innovative approach not only enhances the gaming experience but also aligns with regulatory standards in the lottery sector.
InNetwork
Angel Round in 2012
InNetwork Inc. is a Canadian company that specializes in providing tools for marketers to create and manage social media influencer outreach campaigns. Established in 2012, the company operates from Halifax and Toronto, offering a platform that enables brands to identify and engage trusted social media influencers. InNetwork’s solution is designed to simplify the influencer outreach process, allowing marketers to target specific customer demographics through detailed audience segmentation data. The platform not only connects marketers with a vetted network of influencers but also tracks and measures the effectiveness of influencer activities, ensuring that brands can communicate their messages efficiently and effectively. By streamlining the campaign process, InNetwork helps agencies and brand managers execute influencer outreach at scale, ultimately improving campaign results while saving time. InNetwork operates as a subsidiary of gShift Labs Inc.
DeNovaMed
Seed Round in 2012
DeNovaMed Inc. is an early-stage pharmaceutical company based in Halifax, Nova Scotia, Canada, focused on developing innovative antibiotics to address infections caused by drug-resistant bacteria, commonly known as superbugs. Established in 2006, the company leverages its expertise in drug discovery, microbiology, and bacterial lipid metabolism to create novel therapeutic approaches. DeNovaMed's products aim to enhance the effectiveness of existing antibiotics, particularly in treating skin, wound, and systemic infections. Through its research and development efforts, DeNovaMed seeks to provide healthcare providers with advanced solutions to combat the growing threat of antibiotic resistance.
CarbonCure
Series A in 2012
CarbonCure Technologies Inc. is a Canadian company that specializes in technology designed to sequester carbon dioxide (CO2) in concrete production. Founded in 2007 and headquartered in Dartmouth, Nova Scotia, the company provides a retrofit solution for existing concrete plants, allowing producers to incorporate waste CO2 from industrial emitters into their concrete products. During manufacturing, this CO2 is chemically converted into solid mineral carbonates, enhancing the strength of the concrete while reducing its carbon footprint. CarbonCure's innovative approach enables concrete manufacturers to produce green concrete without compromising quality or cost, thereby facilitating a shift towards sustainable building practices. The company also offers marketing and environmental reporting services to support its customers in the growing green building market. By licensing its technology at a low capital expenditure, CarbonCure generates a recurring revenue stream while contributing to the reduction of greenhouse gas emissions in the concrete industry.
Health Outcomes Worldwide
Venture Round in 2011
Health Outcomes Worldwide, Inc. is a Canadian company that specializes in developing e-health solutions for disease management aimed at healthcare organizations. Founded in 2005 and based in New Waterford, the company offers its flagship product, how2trak, which is a mobile and web-based data outcome measurement solution. This platform enables users to record clinical data related to wound management, diabetes practices, and various clinical indicators. By providing accessible reports, how2trak allows clinicians and managers to monitor patient outcomes and manage clinical practices effectively, thereby enhancing patient care and reducing delivery costs. The solution also facilitates compliance with patient safety standards by enabling surveillance of wound types and outcomes. Overall, Health Outcomes Worldwide aims to improve the quality of care delivered to patients through standardized measurement and evaluation processes.
DGI Clinical
Seed Round in 2001
DGI Clinical Inc. is a Canadian company based in Halifax that specializes in providing clinical metric solutions focused on dementia treatments. It serves pharmaceutical and biotech companies, as well as regulatory and reimbursement agencies, by offering tools that demonstrate clinically meaningful outcomes. The company's flagship product, SymptomGuide, is an interactive disease management tool that enables users to track and manage dementia symptoms over time, generating individualized reports that aid in diagnostic and treatment decisions. DGI Clinical also offers comprehensive support, including training programs for clinical study site initiation and ongoing assistance via telephone and email. With a commitment to innovative health management technologies, the company helps address the significant social and economic challenges posed by dementia, providing valuable data for drug development and efficacy assessments. DGI Clinical was originally founded as DementiaGuide Inc. in 2000 and rebranded in 2011.